Literature DB >> 791197

[Deanol in tardive dyskinesia: a double-blind study (author's transl)].

S Bockenheimer, G Lucius.   

Abstract

Tardive dyskinesia following long-term application of neuroleptics is resistant to treatment. According to the hypothesis of a relative central nervous system acetylcholine lack as the underlying mechanism 20 patients were treated with dimethylaminoethanol (Deanol) in a double-blind study. Deanol is known to be a direct precursor of intracerebral acetylcholine. For several reasons (which are discussed) the data of but 11 patients were statistically evaluated. The results suggest some therapeutic effect in some of the patients only (significant improvement of oral hyperkinesia).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 791197     DOI: 10.1007/bf00369796

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  18 in total

1.  Deanol in tardive dyskinesia.

Authors:  L De Silva; C Y Huang
Journal:  Br Med J       Date:  1975-08-23

2.  Deanol in tardive dyskinesia: a preliminary report.

Authors:  W E Fann; J L Sullivan; R D Miller; G M McKenzie
Journal:  Psychopharmacologia       Date:  1975-05-28

3.  Letter: Choline for tardive dyskinesia.

Authors:  K L Davis; P A Berger; L E Hollister
Journal:  N Engl J Med       Date:  1975-07-17       Impact factor: 91.245

4.  Letter: Dimethylaminoethanol for tardive dyskinesia.

Authors:  J I Escobar; K F Kemp
Journal:  N Engl J Med       Date:  1975-02-06       Impact factor: 91.245

5.  Letter: Deanol: a solution for tardive dyskinesia?

Authors:  E M Miller
Journal:  N Engl J Med       Date:  1974-10-10       Impact factor: 91.245

6.  [On the problem of persistent extrapyramidal hyperkinesia following prolonged use of neuroleptics].

Authors:  R Degkwitz; K F Binsack; H Herkert; O Luxenburger; W Wenzel
Journal:  Nervenarzt       Date:  1967-04       Impact factor: 1.214

Review 7.  [On the problem of the terminal extrapyramidal hyperkineses as observed in 1600 patients during long-term therapy with neuroleptics].

Authors:  R Degkwitz; W Wenzel; K F Binsack; H Herkert; O Luxenburger
Journal:  Arzneimittelforschung       Date:  1966-02

Review 8.  Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.

Authors:  G E Crane
Journal:  Am J Psychiatry       Date:  1968-02       Impact factor: 18.112

9.  Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia.

Authors:  H L Klawans; R R McKendall
Journal:  J Neurol Sci       Date:  1971-10       Impact factor: 3.181

Review 10.  2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action.

Authors:  O Re'
Journal:  Curr Ther Res Clin Exp       Date:  1974-11
View more
  4 in total

1.  Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.

Authors:  C de Montigny; G Chouinard; L Annable
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

2.  [Idiopathic blepharospasm. Clinical and electrophysiological investigations in 27 patients (author's transl)].

Authors:  E Schenck; D Schmidt
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-12-14

Review 3.  Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.

Authors:  Karla Soares-Weiser; John Rathbone; Yusuke Ogawa; Kiyomi Shinohara; Hanna Bergman
Journal:  Cochrane Database Syst Rev       Date:  2018-03-19

Review 4.  Cholinergic medication for antipsychotic-induced tardive dyskinesia.

Authors:  Irina Tammenmaa-Aho; Rosie Asher; Karla Soares-Weiser; Hanna Bergman
Journal:  Cochrane Database Syst Rev       Date:  2018-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.